261 related articles for article (PubMed ID: 2369723)
1. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor stimulates non-mitochondrial Ca2+ uptake and inhibits mitogen-induced Ca2+ signaling in Swiss 3T3 fibroblasts.
Powis G; Seewald MJ; Sehgal I; Iaizzo PA; Olsen RA
J Biol Chem; 1990 Jun; 265(18):10266-73. PubMed ID: 2113051
[TBL] [Abstract][Full Text] [Related]
5. The ether lipid ET-18-OCH3 increases cytosolic Ca2+ concentrations in Madin Darby canine kidney cells.
Jan CR; Wu SN; Tseng CJ
Br J Pharmacol; 1999 Jul; 127(6):1502-10. PubMed ID: 10455302
[TBL] [Abstract][Full Text] [Related]
6. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
7. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J
Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915
[TBL] [Abstract][Full Text] [Related]
9. Halothane inhibits agonist-induced inositol phosphate and Ca2+ signaling in A7r5 cultured vascular smooth muscle cells.
Sill JC; Uhl C; Eskuri S; Van Dyke R; Tarara J
Mol Pharmacol; 1991 Dec; 40(6):1006-13. PubMed ID: 1836833
[TBL] [Abstract][Full Text] [Related]
10. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
11. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
12. Retinyl acetate inhibits platelet-derived growth factor-induced Ca2+ signals in C3H 10T1/2 fibroblasts.
Hill TD; Boynton AL; Dean NM; Mordan LJ
J Cell Physiol; 1990 Aug; 144(2):229-36. PubMed ID: 2380253
[TBL] [Abstract][Full Text] [Related]
13. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
[TBL] [Abstract][Full Text] [Related]
15. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
[TBL] [Abstract][Full Text] [Related]
16. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
[TBL] [Abstract][Full Text] [Related]
17. Role of inositol (1,4,5)trisphosphate in epidermal growth factor-induced Ca2+ signaling in A431 cells.
Hughes AR; Bird GS; Obie JF; Thastrup O; Putney JW
Mol Pharmacol; 1991 Aug; 40(2):254-62. PubMed ID: 1875911
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
Kosano H; Takatani O
Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846
[TBL] [Abstract][Full Text] [Related]
19. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
20. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
